Publications
- Propafenone versus amiodarone for supraventricular arrhythmias in septic shock: a randomised controlled trial2023 | First Faculty of Medicine, Third Faculty of Medicine
- Imaging of COVID-19 in critical care with a focus on chest ultrasound2023 | First Faculty of Medicine
- Prognostic Impact of Serial Imaging in Severe Acute Respiratory Distress Syndrome on the Extracorporeal Membrane Oxygenation2023 | First Faculty of Medicine
- Pulmonary consolidation alters the ultrasound estimate of pleural fluid volume when considering chest drainage in patients on ECMO2022 | First Faculty of Medicine
- The impact of obesity on the outcome of severe SARS-CoV-2 ARDS in a high volume ECMO centre: ECMO and corticosteroids support the obesity paradox2022 | First Faculty of Medicine
- Interpleural location of chest drain on ultrasound excludes pneumothorax and associates with a low degree of chest drain foreshortening on the antero-posterior chest X-ray2022 | First Faculty of Medicine
- Vasopressin in Patients with Septic Shock and Dynamic Left Ventricular Outflow Tract Obstruction2020 | First Faculty of Medicine
- Efficacy and safety of 1C class antiarrhythmic agent (propafenone) for supraventricular arrhythmias in septic shock compared to amiodarone: Protocol of a prospective randomised double-blind study2019 | First Faculty of Medicine, Third Faculty of Medicine
- Propafenone for supraventricular arrhythmias in septic shock-Comparison to amiodarone and metoprolol. Reply2018 | First Faculty of Medicine
- Propafenone for supraventricular arrhythmias in septic shock-Comparison to amiodarone and metoprolol2017 | First Faculty of Medicine, Third Faculty of Medicine
Loading network view...